Olatz Pampliega

Olatz Pampliega

Auto-generated profile, based on publicly available information

Olatz Pampliega

Department of Neurosciences, University of the Basque Country, Achucarro Basque Center for Neuroscience-UPV/EHU

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 October 2013 in Nature
Verified
Journal Article
Open access
PDF file
OPOlatz Pampliega
Olatz Pampliega
IOIdil Orhon
Idil Orhon
BPBindi Patel
Bindi Patel
SSSunandini Sridhar
Sunandini Sridhar
ADAntonio Díaz-Carretero
Antonio Díaz-Carretero
ACAna Maria Cuervo
Ana Maria Cuervo
Nutrient deprivation is a stimulus shared by both autophagy and the formation of primary cilia. The recently discovered role of primary cilia in nutrient sensing and signalling motivated us to explore the possible functional interactions between this signalling hub and autophagy. Here we show that part of the molecular machinery involved in ciliogenesis also participates in the early steps of the autophagic process. Signalling from the cilia, such as that from the Hedgehog pathway, induces autophagy by acting directly on essential autophagy-related proteins strategically located in the base of the cilium by ciliary trafficking proteins. Whereas abrogation of ciliogenesis partially inhibits autophagy, blockage of autophagy enhances primary cilia growth and cilia-associated signalling during normal nutritional conditions. We propose that basal autophagy regulates ciliary growth through the degradation of proteins required for intraflagellar transport. Compromised ability to activate the autophagic response may underlie some common ciliopathies.

1 September 2018 in The Lancet Neurology
Verified
Journal Article
Closed access
ASAurora Scrivo
Aurora Scrivo
MBMathieu Bourdenx
Mathieu Bourdenx
OPOlatz Pampliega
Olatz Pampliega
ACAna Maria Cuervo
Ana Maria Cuervo

24 September 2021 in Ageing Research Reviews
Verified
Journal Article
Closed access
SKSusmita Kaushik
Susmita Kaushik
ITInmaculada Tasset
Inmaculada Tasset
EAEsperanza Arias
Esperanza Arias
OPOlatz Pampliega
Olatz Pampliega
EWEsther Wong
Esther Wong
ACAna Maria Cuervo
Ana Maria Cuervo

22 December 2009 in Glia
Verified
Journal Article
Closed access
PDF file
MDMaria Domercq
Maria Domercq
APAlberto Perez‐Samartin
Alberto Perez‐Samartin
DADavid Aparicio
David Aparicio
EAElena Alberdi
Elena Alberdi
OPOlatz Pampliega
Olatz Pampliega
Carlos MatuteCarlos Matute
Carlos Matute

31 January 2017 in Frontiers in Neuroscience
Verified
Journal Article
Open access
FSFederico Soria
Federico Soria
OPOlatz Pampliega
Olatz Pampliega
MBMathieu Bourdenx
Mathieu Bourdenx
WMWassilios Meissner
Wassilios Meissner
Erwan BezardErwan Bezard
Erwan Bezard
BDBenjamin DEHAY
Benjamin DEHAY
Exosomes are extracellular nanovesicles (30-100 nm) generated from endosomal membranes and known to be released by all cell lineages of the Central Nervous System (CNS). They constitute important vesicles for the secretion and transport of multilevel information, including signaling, toxic and regulatory molecules. Initially thought to have a function merely in waste disposal, the involvement of exosomes in neuronal development, maintenance and regeneration through its paracrine and endocrine signaling functions has drawn particular attention in recent years. These vesicles, being involved in the clearance and cell-to-cell spreading of toxic molecules, have been naturally implicated in aging, and in several neurodegenerative diseases associated with pathological conversion of proteins, as well as in the transport of other disease-associated molecules, such as nucleic acids or pro-inflammatory cytokines. Our understanding of such unique form of communication may provide not only answers about (patho)physiological processes in the brain, but can also offer means to exploit these vesicles as vehicles for the delivery of biologically relevant molecules or as tools to monitor brain diseases in a non-invasive way. A promising field in expansion, the study of exosomes and related extracellular vesicles has just commenced to unveil their potential as therapeutic tools for brain disorders as well as biomarkers of disease state.

3 June 2011 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
OPOlatz Pampliega
Olatz Pampliega
MDMaria Domercq
Maria Domercq
FSFederico Soria
Federico Soria
PVPablo Villoslada
Pablo Villoslada
ARAlfredo Rodríguez-Antigüedad
Alfredo Rodríguez-Antigüedad
Carlos MatuteCarlos Matute
Carlos Matute
Background: Glutamate excitotoxicity contributes to oligodendrocyte and tissue damage in multiple sclerosis (MS). Intriguingly, glutamate level in plasma and cerebrospinal fluid of MS patients is elevated, a feature which may be related to the pathophysiology of this disease. In addition to glutamate transporters, levels of extracellular glutamate are controlled by cystine/glutamate antiporter xc-, an exchanger that provides intracellular cystine for production of glutathione, the major cellular antioxidant. The objective of this study was to analyze the role of the system xc-in glutamate homeostasis alterations in MS pathology.Methods: Primary cultures of human monocytes and the cell line U-937 were used to investigate the mechanism of glutamate release. Expression of cystine glutamate exchanger (xCT) was quantified by quantitative PCR, Western blot, flow cytometry and immunohistochemistry in monocytes in vitro, in animals with experimental autoimmune encephalomyelitis (EAE), the animal model of MS, and in samples of MS patients.Results and discussion: We show here that human activated monocytes release glutamate through cystine/glutamate antiporter xc-and that the expression of the catalytic subunit xCT is upregulated as a consequence of monocyte activation. In addition, xCT expression is also increased in EAE and in the disease proper. In the later, high expression of xCT occurs both in the central nervous system (CNS) and in peripheral blood cells. In particular, cells from monocyte-macrophage-microglia lineage have higher xCT expression in MS and in EAE, indicating that immune activation upregulates xCT levels, which may result in higher glutamate release and contribution to excitotoxic damage to oligodendrocytes.Conclusions: Together, these results reveal that increased expression of the cystine/glutamate antiporter system xc-in MS provides a link between inflammation and excitotoxicity in demyelinating diseases.